Merck Beats 295 Zostavax Suits Over Missed Deadlines

By P.J. D'Annunzio · April 9, 2026, 6:16 PM EDT

A Pennsylvania federal judge has tossed 295 cases against Merck & Co. Inc. in the multidistrict litigation alleging its Zostavax shingles vaccine caused the disease, with the court reasoning that the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

IN RE: ZOSTAVAX (ZOSTER VACCINE LIVE) PRODUCTS LIABILITY LITIGATION

Case Number

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

August 02, 2018

Recent Articles By P.J.

April 09, 2026
Philly Injection Site Row Judge Rejects Nonprofit's 'Ploy'
April 07, 2026
Jury Awards $39.5M Over Discharged Psych Patient's Victims
April 06, 2026
Paperwork Lapse Led To 'Horrific' Family Slayings, Jury Told
March 23, 2026
Healthcare Co. Liable For Patient's Killings, Philly Jury Told
March 20, 2026
Pa. Hospital Must Pay $109M For Brain Injury During Birth
March 12, 2026
Epilepsy Drugmaker's Statements Insulated From Stock Suit
March 11, 2026
Pa. Justices Hint 3rd Jury Should Decide Misdiagnosis Case
March 11, 2026
Aetna Will Pay $117.7M To Resolve False Billing Suit
February 26, 2026
Health Plans Lack Expert In Avandia MDL, 3rd Circ. Told
February 25, 2026
Philly Says PBMs Can't Exit Suit Over Opioid Crisis